Metro-Minnesota Community Oncology Research Consortium — Saint Paul, Minnesota

Metro-Minnesota Community Oncology Research Consortium is a clinical research site located in Saint Paul, Minnesota, United States 55101-2502.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Metro-Minnesota Community Oncology Research Consortium has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Breast Cancer, Non-small Cell Lung Cancer, NSCLC.

Sponsors: Hoffmann-La Roche, BeiGene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Saint Paul

Browse all research sites in Minnesota · View every site in Saint Paul

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro-Minnesota Community Oncology Research Consortium?

Metro-Minnesota Community Oncology Research Consortium has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro-Minnesota Community Oncology Research Consortium conducted?

Metro-Minnesota Community Oncology Research Consortium has 2 clinical trials on record, with 1 currently active. Their work covers Metastatic Breast Cancer, Non-small Cell Lung Cancer, NSCLC.

Is Metro-Minnesota Community Oncology Research Consortium accredited by Crixeo Clinical Trials?

Metro-Minnesota Community Oncology Research Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metro-Minnesota Community Oncology Research Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.